Anti-Ro52 Antibodies and Interstitial Lung Disease in Connective Tissue Diseases Excluding Scleroderma

Table 2

Distribution of anti-Ro52 antibodies through connective tissue diseases.

	PM/DM 𝑛 (%)	SLE 𝑛 (%)	Sjögren 𝑛 (%)	Mixed CTD 𝑛 (%)	U CTD 𝑛 (%)	P Neo 𝑛 (%)	P
PARo52A	13 (76.5)	7 (77.8)	2 (100)	8 (100)	3 (100)	2 (100)	0.668*

PARo52A, positive anti-Ro52 antibodies; PM/DM, polymyositis dermatomyositis; SLE, systemic lupus erythematosus; CTD, connective tissue diseases; U, undifferentiated; P Neo, paraneoplastic.
*Fischer test.